Depressive Disorders - Latvia

  • Latvia
  • Revenue in the Depressive Disorders market is projected to reach US$4.47m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.39%, resulting in a market volume of US$4.79m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$46.74 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Latvia has been experiencing significant growth in recent years, driven by changing customer preferences and a number of local special circumstances.

Customer preferences:
Customers in Latvia are increasingly seeking out treatment options for depressive disorders, leading to a growing demand for medications and therapies. This can be attributed to a number of factors, including a greater awareness and understanding of mental health issues, an aging population, and an increased willingness to seek help for mental health problems. Additionally, the COVID-19 pandemic has had a significant impact on mental health worldwide, including in Latvia, leading to an increased need for treatment options for depressive disorders.

Trends in the market:
One of the key trends in the Depressive Disorders market in Latvia is the growing popularity of alternative and complementary therapies. Many customers are seeking out non-pharmaceutical treatment options, such as psychotherapy, mindfulness-based therapies, and herbal remedies. This trend is driven by a desire for more holistic and personalized approaches to treatment, as well as concerns about the potential side effects of pharmaceutical medications. As a result, there has been a rise in the availability and accessibility of these alternative therapies in the market.Another trend in the market is the increasing use of digital health solutions for the treatment of depressive disorders. Mobile applications, online therapy platforms, and virtual support groups are becoming more widely used by customers in Latvia. These digital solutions offer convenience, privacy, and accessibility, making them attractive options for individuals seeking treatment for depressive disorders. The COVID-19 pandemic has further accelerated the adoption of digital health solutions, as face-to-face interactions have been limited.

Local special circumstances:
Latvia has a relatively high prevalence of depressive disorders compared to other countries. This can be attributed to a number of factors, including a history of political and economic instability, high levels of social inequality, and limited access to mental health services in certain regions. These special circumstances have created a greater need for effective treatment options for depressive disorders in Latvia.

Underlying macroeconomic factors:
Latvia has experienced steady economic growth in recent years, which has contributed to an increase in healthcare spending. The government has been investing in the development of mental health services, including the provision of training for healthcare professionals and the expansion of mental health facilities. This increased investment in mental health infrastructure has helped to drive the growth of the Depressive Disorders market in Latvia.In conclusion, the Depressive Disorders market in Latvia is experiencing growth due to changing customer preferences, including a demand for alternative and complementary therapies, as well as the increasing use of digital health solutions. Local special circumstances, such as a high prevalence of depressive disorders and limited access to mental health services, have also contributed to the growth of the market. Furthermore, underlying macroeconomic factors, such as economic growth and increased investment in mental health services, have supported the development of the market in Latvia.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)